# Abbott Laboratories: Form 8-K, filed Oct 15, 2025

- Company: [Abbott Laboratories](/companies/abt.md) (CIK 1800)
- Form: 8-K
- Filed: 2025-10-15
- Accepted by EDGAR: Oct 15, 2025, 11:33 ET
- Period: 2025-10-15
- Accession: 0001628280-25-045049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1800/000162828025045049/abt-20251015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1800/000162828025045049/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1800/000162828025045049/abt-20251015.htm

Filed Oct 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-045049. Last ingested by Listed: Oct 24, 2026, 14:50 ET. No prices; not investment advice.